Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Johnson

Showing results (481-490 of 514) with videos related to

Pageof 52
Sort By:
Antimicrobial Agents and Chemotherapy|January 22, 2013
Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremiaNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2013
Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemiaN E Holmes, J D Turnidge, W J Munckhof, et al.
Elife|April 14, 2023
Statistical modeling based on structured surveys of Australian native possum excreta harboring <i>Mycobacterium ulcerans</i> predicts Buruli ulcer occurrence in humansKoen Vandelannoote, Andrew H Buultjens, Jessica L Porter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2010
Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiencyC L Gordon, P D R Johnson, M Permezel, et al.
The Journal of Infectious Diseases|July 12, 2011
Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrationsNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
Journal of the American Medical Directors Association|February 22, 2023
Severity of COVID-19 among Residents in Aged Care Facilities in Victoria, Australia: A Retrospective Cohort Study Comparing the Delta and Omicron Epidemic PeriodsMichael Muleme, Bridgette J McNamara, Frances H Ampt, et al.
Applied and Environmental Microbiology|November 18, 2025
Defining new Buruli ulcer endemic areas in urban southeastern Australia using bacterial genomics-informed possum excreta surveysAndrew H Buultjens, Koen Vandelannoote, Jessica L Porter, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 15, 2026
Comparative real-world analysis of stereotactic body radiotherapy versus conventional radiotherapy for Chinese patients with low- to intermediate-risk localised prostate cancerB H W Lam, E K H Chan, O L Wong, et al.
Peerj|February 3, 2017
Evolutionary origins of the emergent ST796 clone of vancomycin resistant <i>Enterococcus faecium</i>Andrew H Buultjens, Margaret M C Lam, Susan Ballard, et al.
Plos Neglected Tropical Diseases|November 26, 2009
Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcerNicholas J Tobias, Torsten Seemann, Sacha J Pidot, et al.
Pageof 52

Showing results (481-490 of 514) with videos related to

Sort By:
Pageof 52
Antimicrobial Agents and Chemotherapy|January 22, 2013
Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremiaNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2013
Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemiaN E Holmes, J D Turnidge, W J Munckhof, et al.
Elife|April 14, 2023
Statistical modeling based on structured surveys of Australian native possum excreta harboring <i>Mycobacterium ulcerans</i> predicts Buruli ulcer occurrence in humansKoen Vandelannoote, Andrew H Buultjens, Jessica L Porter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2010
Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiencyC L Gordon, P D R Johnson, M Permezel, et al.
The Journal of Infectious Diseases|July 12, 2011
Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrationsNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
Journal of the American Medical Directors Association|February 22, 2023
Severity of COVID-19 among Residents in Aged Care Facilities in Victoria, Australia: A Retrospective Cohort Study Comparing the Delta and Omicron Epidemic PeriodsMichael Muleme, Bridgette J McNamara, Frances H Ampt, et al.
Applied and Environmental Microbiology|November 18, 2025
Defining new Buruli ulcer endemic areas in urban southeastern Australia using bacterial genomics-informed possum excreta surveysAndrew H Buultjens, Koen Vandelannoote, Jessica L Porter, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 15, 2026
Comparative real-world analysis of stereotactic body radiotherapy versus conventional radiotherapy for Chinese patients with low- to intermediate-risk localised prostate cancerB H W Lam, E K H Chan, O L Wong, et al.
Peerj|February 3, 2017
Evolutionary origins of the emergent ST796 clone of vancomycin resistant <i>Enterococcus faecium</i>Andrew H Buultjens, Margaret M C Lam, Susan Ballard, et al.
Plos Neglected Tropical Diseases|November 26, 2009
Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcerNicholas J Tobias, Torsten Seemann, Sacha J Pidot, et al.
Pageof 52